BR0009177A - Processo para preparação de uma forma de dosagem oral biodisponìvel de axetil cefuroxima - Google Patents

Processo para preparação de uma forma de dosagem oral biodisponìvel de axetil cefuroxima

Info

Publication number
BR0009177A
BR0009177A BR0009177-4A BR0009177A BR0009177A BR 0009177 A BR0009177 A BR 0009177A BR 0009177 A BR0009177 A BR 0009177A BR 0009177 A BR0009177 A BR 0009177A
Authority
BR
Brazil
Prior art keywords
dosage form
oral dosage
preparing
bioavailable oral
axetil cefuroxime
Prior art date
Application number
BR0009177-4A
Other languages
English (en)
Inventor
Krishan Somani Jitendra
Indu Brushan
Sen Himadri
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN453DE1999 external-priority patent/IN190831B/en
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of BR0009177A publication Critical patent/BR0009177A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"PROCESSO PARA PREPARAçãO DE UMA FORMA DE DOSAGEM ORAL BIODISPONìVEL DE AXETIL CEFUROXIMA". A presente invenção se refere a um processo de mistura de um composto de axetil cefuroxima cristalino com um composto de axetil cefuroxima amorfo, para preparação de uma forma de dosagem oral biodisponível, compreendendo o composto de axetil cefuroxima amorfo contendo de 7 a 25% do composto de axetil cefuroxima cristalino.
BR0009177-4A 1999-03-19 2000-03-17 Processo para preparação de uma forma de dosagem oral biodisponìvel de axetil cefuroxima BR0009177A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN453DE1999 IN190831B (pt) 1999-03-19 1999-03-19
US09/366,986 US6346530B1 (en) 1999-03-19 1999-08-04 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil
PCT/IB2000/000292 WO2000056286A1 (en) 1999-03-19 2000-03-17 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil

Publications (1)

Publication Number Publication Date
BR0009177A true BR0009177A (pt) 2002-01-22

Family

ID=26324612

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009177-4A BR0009177A (pt) 1999-03-19 2000-03-17 Processo para preparação de uma forma de dosagem oral biodisponìvel de axetil cefuroxima

Country Status (10)

Country Link
US (1) US6323193B1 (pt)
EP (1) EP1165051B1 (pt)
AT (1) ATE244560T1 (pt)
AU (1) AU3184300A (pt)
BR (1) BR0009177A (pt)
CA (1) CA2366617A1 (pt)
ES (1) ES2202069T3 (pt)
HK (1) HK1043540B (pt)
PT (1) PT1165051E (pt)
WO (1) WO2000056286A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA006777B1 (ru) * 2001-06-22 2006-04-28 Пфайзер Продактс Инк. Фармацевтические композиции адсорбатов аморфного лекарственного средства
WO2005002540A2 (en) * 2003-07-01 2005-01-13 Ranbaxy Laboratories Limited Dry powder pharmaceutical suspension compositions of cefuroxime axetil
GB0400971D0 (en) * 2004-01-16 2004-02-18 Sandoz Ag Pharmaceutical compositions
US8188067B2 (en) 2004-04-01 2012-05-29 Teva Pharmaceutical Industries Ltd. Formulations of 6-mercaptopurine
EA200601597A1 (ru) * 2004-04-01 2007-04-27 Тева Фармасьютикал Индастриес Лтд. Композиции 6-меркаптопурина задержанного выделения
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
US8900637B2 (en) 2005-12-02 2014-12-02 Lupin Limited Stable taste masked formulations of cephalosporins
WO2009128955A1 (en) * 2008-04-18 2009-10-22 Teva Pharmaceutical Industries Ltd. Treatment of inflammatory bowel disease with 6-mercaptopurine
US8324426B2 (en) * 2008-08-28 2012-12-04 Telik, Inc. Formulations of canfosfamide and their preparation
US20100056825A1 (en) * 2008-08-28 2010-03-04 Telik, Inc. Formulations of canfosfamide and their preparation
WO2011139254A2 (en) * 2010-05-04 2011-11-10 Mahmut Bilgic Pharmaceutical formulations compising cefuroxime axetil
WO2013100880A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Formulations comprising cefuroxime
US8313774B1 (en) * 2012-06-26 2012-11-20 Magnifica Inc. Oral solid composition
EP3362053A4 (en) 2015-10-16 2019-04-17 Hadasit Medical Research Services and Development Ltd. TREATMENT OF NON-ALCOHOLIC FATTYLENE OR NON-ALCOHOLIC STEATOHEPATITIS WITH 6-MERCAPTOPURIN WITH DELAYED RELEASE
EP3668515A4 (en) * 2017-08-18 2021-05-12 Abbvie Inc. PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF ENDOMETRIOSIS, UTERINE FIBROMAS, POLYCYSTIC OVARY SYNDROME OR ADENOMYOSIS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1094545A (en) 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
YU44680B (en) 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
KR100187959B1 (ko) * 1997-03-31 1999-06-01 윤재승 저융점 무정형 세푸록심 악세틸의 제조방법
IN186539B (pt) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
EP1165051A1 (en) 2002-01-02
ATE244560T1 (de) 2003-07-15
US6323193B1 (en) 2001-11-27
WO2000056286A1 (en) 2000-09-28
EP1165051B1 (en) 2003-07-09
ES2202069T3 (es) 2004-04-01
HK1043540B (zh) 2003-12-24
AU3184300A (en) 2000-10-09
HK1043540A1 (en) 2002-09-20
CA2366617A1 (en) 2000-09-28
PT1165051E (pt) 2003-11-28

Similar Documents

Publication Publication Date Title
BR0009177A (pt) Processo para preparação de uma forma de dosagem oral biodisponìvel de axetil cefuroxima
HUP0002987A2 (hu) Cefdinir diciklohexil-amin sója és eljárás a só előállítására valamint a vegyület sójából történő felszabadítására
EA199700124A1 (ru) Производные гуанина
NO20071547L (no) Nye krystallinske og amorfe former av en triazolo(4,5-D)pyrimidinforbindelse
SI1535613T1 (sl) Postopek za pripravo polimorfne oblike atorvastatin kalcija
IL156280A0 (en) Crystalline forms of atorvastatin
AU5649601A (en) Synthetic process for the manufacture of an ecteinaschidin compound
CY1111600T1 (el) Αμορφη ριτοναβιρη
DE60015228D1 (de) Verfahren zur Herstellung von kristallinem Silizium
BR9804857A (pt) Processo para a produ-Æo fermentativa de ceffalosporinas desaciladas
ITMI951716A0 (it) Forma cristallina biodisponibile del cefuroxima axetil
TW200420541A (en) Crystalline forms
MXPA02001813A (es) Hidroxialcanoilaminolactamas y estructuras relacionas como inhibidores de la produccion de la proteina abeta.
SG99351A1 (en) Process for the manufacture of a crystalline solid
AU2002245005A1 (en) Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor
FR2796641B1 (fr) Nouveau procede de preparation de composes benzoperhydroisoindole
BR0114156A (pt) Forma amorfa de inibidor de ciclo de célula
HU0300761D0 (en) Process for the production of amorphous atorvastatin calcium
PT831820E (pt) Composicao farmaceutica oral de compostos de piperidinoalcanol em forma de solucao
MXPA02009210A (es) Modificacion amorfa de torasemida.
AU2003212351A8 (en) A process for the preparation of cephalosporan acid derivatives from cephalosporin c
HUP0300869A3 (en) Process for the purification of a salt of clavulanic acid
CO5080739A1 (es) Compuestos antibacterianos de cefalosporinas de 7-acilamino- 3-(amino-guanidina ciclica) metileno utiles como productos farmaceuticos y procesos para su produccion
NO20006073L (no) Fremgangsmåte for fremstilling av krystallinske salter av amoxycillin
PT1212095E (pt) Processo para a preparacao de uma formulacao de libertacao retardada

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.